找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Adjuvant Therapy of Breast Cancer V; Hans J?rg Senn,Richard D. Gelber,Beat Thürlimann Conference proceedings 1996 Springer-Verlag Berlin H

[復(fù)制鏈接]
查看: 9362|回復(fù): 54
樓主
發(fā)表于 2025-3-21 17:45:41 | 只看該作者 |倒序瀏覽 |閱讀模式
期刊全稱Adjuvant Therapy of Breast Cancer V
影響因子2023Hans J?rg Senn,Richard D. Gelber,Beat Thürlimann
視頻videohttp://file.papertrans.cn/145/144981/144981.mp4
學(xué)科分類Recent Results in Cancer Research
圖書封面Titlebook: Adjuvant Therapy of Breast Cancer V;  Hans J?rg Senn,Richard D. Gelber,Beat Thürlimann Conference proceedings 1996 Springer-Verlag Berlin H
影響因子We often hear physicians, health care professionals, poli- ticians, and patient advocates that "nothing has happened in the treatment of breast cancer," since patients with breast cancer, the most frequent neoplastic condition in women in industrialized countries, are continuing to suffer relapse and succumb to this dreadful disease! This negativistic attitude does not seem to be justified, but, why is the transmission of clinical trial results into general practice, and with it progress, such a slow process? After many decades of frustrating stagnation of long-term survival expectations, in all stages of early, oper/lble breast cancer treated only by surgery and locoregional radio- therapy, adjuvant systemic therapy (chemo- as well as endocrine treatments) clearly showed to significantly benefit in terms of disease-free and overall survival. This evolution has been extensively expounded on by the Worldwide Oxford Overview and the Expert Consensus Panel at the fourth International Conference ‘on Adjuvant Therapy of Primary Breast Cancer in St. Gallen (Early Breast Cancer Trialists‘ Collaborative Group 1992; Glick et al. 1992). What has happened since then? During the past 3-5 years
Pindex Conference proceedings 1996
The information of publication is updating

書目名稱Adjuvant Therapy of Breast Cancer V影響因子(影響力)




書目名稱Adjuvant Therapy of Breast Cancer V影響因子(影響力)學(xué)科排名




書目名稱Adjuvant Therapy of Breast Cancer V網(wǎng)絡(luò)公開度




書目名稱Adjuvant Therapy of Breast Cancer V網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Adjuvant Therapy of Breast Cancer V被引頻次




書目名稱Adjuvant Therapy of Breast Cancer V被引頻次學(xué)科排名




書目名稱Adjuvant Therapy of Breast Cancer V年度引用




書目名稱Adjuvant Therapy of Breast Cancer V年度引用學(xué)科排名




書目名稱Adjuvant Therapy of Breast Cancer V讀者反饋




書目名稱Adjuvant Therapy of Breast Cancer V讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:20:36 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:07:45 | 只看該作者
地板
發(fā)表于 2025-3-22 06:49:09 | 只看該作者
Conference proceedings 1996 on by the Worldwide Oxford Overview and the Expert Consensus Panel at the fourth International Conference ‘on Adjuvant Therapy of Primary Breast Cancer in St. Gallen (Early Breast Cancer Trialists‘ Collaborative Group 1992; Glick et al. 1992). What has happened since then? During the past 3-5 years
5#
發(fā)表于 2025-3-22 10:23:41 | 只看該作者
6#
發(fā)表于 2025-3-22 12:59:05 | 只看該作者
7#
發(fā)表于 2025-3-22 19:45:54 | 只看該作者
8#
發(fā)表于 2025-3-22 23:35:24 | 只看該作者
9#
發(fā)表于 2025-3-23 04:45:44 | 只看該作者
Peptide Growth Factors and Breast Cancer Treatment: Recent Translational Researche can be fed without increasing the risk of NEC or long term adverse effects. This chapter provides a close scrutiny of the current evidence to assess if the safe upper limits of various aspects of aggressive enteral feeding of extremely preterm neonates are well defined and adequately assessed. The
10#
發(fā)表于 2025-3-23 08:55:23 | 只看該作者
Single-Chain Fusion Toxins for the Treatment of Breast Cancer: Antitumor Activity of BR96 sFv-PE40 ad synthetischen Anwendungen. auf die Reaktionsmechanismen. Es behandelt über 300 klassische und moderne Namensreaktionen...Die übersetzung wurde mit künstlicher Intelligenz erstellt. Um eine hohe Qualit?t der übersetzung zu gew?hrleisten, wurde sie anschlie?end durch den Autor (mit der freundlichen
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-31 03:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
吉木乃县| 黎平县| 诏安县| 万载县| 大渡口区| 洛川县| 神木县| 芦溪县| 开化县| 香港 | 东莞市| 长子县| 辽阳市| 息烽县| 石首市| 彰化县| 新丰县| 平定县| 双峰县| 南溪县| 南木林县| 从化市| 德化县| 凭祥市| 成都市| 清徐县| 应用必备| 凤山市| 枝江市| 区。| 城口县| 体育| 宜城市| SHOW| 新邵县| 平谷区| 万山特区| 崇明县| 舟曲县| 青浦区| 固安县|